

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 8.20213945 |
| 2 | regulation of guanylate cyclase activity (GO:0031282) | 7.55834475 |
| 3 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 7.53138025 |
| 4 | virion attachment to host cell (GO:0019062) | 7.31509763 |
| 5 | adhesion of symbiont to host cell (GO:0044650) | 7.31509763 |
| 6 | phospholipid efflux (GO:0033700) | 7.03714829 |
| 7 | regulation of cholesterol esterification (GO:0010872) | 6.96385821 |
| 8 | positive regulation of triglyceride lipase activity (GO:0061365) | 6.84703581 |
| 9 | positive regulation of lipoprotein lipase activity (GO:0051006) | 6.84703581 |
| 10 | regulation of triglyceride catabolic process (GO:0010896) | 6.58984046 |
| 11 | fat-soluble vitamin biosynthetic process (GO:0042362) | 6.37355564 |
| 12 | plasma lipoprotein particle assembly (GO:0034377) | 6.21354842 |
| 13 | flavonoid metabolic process (GO:0009812) | 6.14007683 |
| 14 | positive regulation of guanylate cyclase activity (GO:0031284) | 6.04986460 |
| 15 | adhesion of symbiont to host (GO:0044406) | 6.04852253 |
| 16 | protein-lipid complex assembly (GO:0065005) | 5.89773665 |
| 17 | fructose metabolic process (GO:0006000) | 5.67941575 |
| 18 | actin filament depolymerization (GO:0030042) | 5.58756724 |
| 19 | digestive system process (GO:0022600) | 5.49905787 |
| 20 | cholesterol efflux (GO:0033344) | 5.49024347 |
| 21 | drug catabolic process (GO:0042737) | 5.46982767 |
| 22 | hormone catabolic process (GO:0042447) | 5.45381696 |
| 23 | lipoprotein metabolic process (GO:0042157) | 5.21919504 |
| 24 | regulation of cellular extravasation (GO:0002691) | 5.14991665 |
| 25 | modified amino acid transport (GO:0072337) | 5.06091994 |
| 26 | reverse cholesterol transport (GO:0043691) | 5.03173373 |
| 27 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 4.94222594 |
| 28 | drug metabolic process (GO:0017144) | 4.93095179 |
| 29 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.90942651 |
| 30 | drinking behavior (GO:0042756) | 4.89840929 |
| 31 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 4.77746606 |
| 32 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 4.77746606 |
| 33 | peptide catabolic process (GO:0043171) | 4.75347554 |
| 34 | peptide hormone processing (GO:0016486) | 4.74653693 |
| 35 | diacylglycerol metabolic process (GO:0046339) | 4.65497511 |
| 36 | urea cycle (GO:0000050) | 4.64583632 |
| 37 | bile acid and bile salt transport (GO:0015721) | 4.60732705 |
| 38 | regulation of cGMP biosynthetic process (GO:0030826) | 4.58039062 |
| 39 | digestion (GO:0007586) | 4.55858717 |
| 40 | glucose 6-phosphate metabolic process (GO:0051156) | 4.55066689 |
| 41 | cellular glucuronidation (GO:0052695) | 4.51382810 |
| 42 | high-density lipoprotein particle remodeling (GO:0034375) | 4.47915861 |
| 43 | glucuronate metabolic process (GO:0019585) | 4.47848798 |
| 44 | uronic acid metabolic process (GO:0006063) | 4.47848798 |
| 45 | urea metabolic process (GO:0019627) | 4.44795893 |
| 46 | purine nucleotide salvage (GO:0032261) | 4.43845904 |
| 47 | cholesterol transport (GO:0030301) | 4.41259990 |
| 48 | sterol transport (GO:0015918) | 4.41259990 |
| 49 | glycolipid catabolic process (GO:0019377) | 4.32064954 |
| 50 | antibacterial humoral response (GO:0019731) | 4.32064774 |
| 51 | cholesterol homeostasis (GO:0042632) | 4.30919404 |
| 52 | glycosphingolipid catabolic process (GO:0046479) | 4.26622967 |
| 53 | sterol homeostasis (GO:0055092) | 4.26247095 |
| 54 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.25249889 |
| 55 | lipoprotein transport (GO:0042953) | 4.22972303 |
| 56 | negative regulation of sterol transport (GO:0032372) | 4.18742101 |
| 57 | negative regulation of cholesterol transport (GO:0032375) | 4.18742101 |
| 58 | regulation of lipoprotein metabolic process (GO:0050746) | 4.18477124 |
| 59 | response to hepatocyte growth factor (GO:0035728) | 4.17508670 |
| 60 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 4.17508670 |
| 61 | antimicrobial humoral response (GO:0019730) | 4.16716901 |
| 62 | protein-lipid complex remodeling (GO:0034368) | 4.15987064 |
| 63 | macromolecular complex remodeling (GO:0034367) | 4.15987064 |
| 64 | plasma lipoprotein particle remodeling (GO:0034369) | 4.15987064 |
| 65 | positive regulation of triglyceride metabolic process (GO:0090208) | 4.12295418 |
| 66 | nitrogen cycle metabolic process (GO:0071941) | 4.10568632 |
| 67 | response to hydroperoxide (GO:0033194) | 4.02288813 |
| 68 | plasma lipoprotein particle organization (GO:0071827) | 3.97205949 |
| 69 | protein-lipid complex subunit organization (GO:0071825) | 3.93329710 |
| 70 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.91104746 |
| 71 | regulation of vitamin metabolic process (GO:0030656) | 3.86809317 |
| 72 | cellular response to nitric oxide (GO:0071732) | 3.85274930 |
| 73 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.84520775 |
| 74 | renal system process involved in regulation of blood volume (GO:0001977) | 3.83644649 |
| 75 | regulation of cGMP metabolic process (GO:0030823) | 3.81192292 |
| 76 | NADH metabolic process (GO:0006734) | 3.78485976 |
| 77 | alkaloid metabolic process (GO:0009820) | 3.78030679 |
| 78 | oligosaccharide catabolic process (GO:0009313) | 3.77992622 |
| 79 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.77213146 |
| 80 | homocysteine metabolic process (GO:0050667) | 3.74471429 |
| 81 | positive regulation of lipid catabolic process (GO:0050996) | 3.74021044 |
| 82 | positive regulation of pseudopodium assembly (GO:0031274) | 3.68689393 |
| 83 | regulation of bile acid biosynthetic process (GO:0070857) | 3.68310505 |
| 84 | mRNA modification (GO:0016556) | 3.68019248 |
| 85 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.65196873 |
| 86 | vitamin transmembrane transport (GO:0035461) | 3.64638195 |
| 87 | response to phenylpropanoid (GO:0080184) | 3.64257677 |
| 88 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.63413296 |
| 89 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.63413296 |
| 90 | endocrine process (GO:0050886) | 3.63413296 |
| 91 | vitamin transport (GO:0051180) | 3.62436998 |
| 92 | sulfation (GO:0051923) | 3.58683808 |
| 93 | sphingomyelin metabolic process (GO:0006684) | 3.58189142 |
| 94 | arginine metabolic process (GO:0006525) | 3.53687718 |
| 95 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.52342927 |
| 96 | regulation of digestive system process (GO:0044058) | 3.49848215 |
| 97 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.49309975 |
| 98 | midgut development (GO:0007494) | 3.46990710 |
| 99 | thyroid hormone metabolic process (GO:0042403) | 3.44910725 |
| 100 | ceramide catabolic process (GO:0046514) | 3.44466038 |
| 101 | epoxygenase P450 pathway (GO:0019373) | 3.43055023 |
| 102 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.41340207 |
| 103 | exogenous drug catabolic process (GO:0042738) | 3.40497204 |
| 104 | glycosylceramide metabolic process (GO:0006677) | 3.39992400 |
| 105 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.38666263 |
| 106 | bile acid metabolic process (GO:0008206) | 3.38211243 |
| 107 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.37448238 |
| 108 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.37363061 |
| 109 | sulfate transmembrane transport (GO:1902358) | 3.35965885 |
| 110 | response to nitric oxide (GO:0071731) | 3.35872798 |
| 111 | innate immune response in mucosa (GO:0002227) | 3.34379725 |
| 112 | vitamin biosynthetic process (GO:0009110) | 3.34336493 |
| 113 | cytidine deamination (GO:0009972) | 3.33369212 |
| 114 | cytidine metabolic process (GO:0046087) | 3.33369212 |
| 115 | cytidine catabolic process (GO:0006216) | 3.33369212 |
| 116 | nucleobase catabolic process (GO:0046113) | 3.31783980 |
| 117 | regulation of pseudopodium assembly (GO:0031272) | 3.29797188 |
| 118 | regulation of cholesterol transport (GO:0032374) | 3.29161768 |
| 119 | regulation of sterol transport (GO:0032371) | 3.29161768 |
| 120 | cellular response to reactive nitrogen species (GO:1902170) | 3.26667765 |
| 121 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.25487118 |
| 122 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.23353790 |
| 123 | sulfur compound transport (GO:0072348) | 3.22607837 |
| 124 | hydrogen peroxide catabolic process (GO:0042744) | 3.22466036 |
| 125 | cellular response to oxygen radical (GO:0071450) | 3.22408494 |
| 126 | removal of superoxide radicals (GO:0019430) | 3.22408494 |
| 127 | cellular response to superoxide (GO:0071451) | 3.22408494 |
| 128 | regulation of cholesterol homeostasis (GO:2000188) | 3.21999264 |
| 129 | transepithelial transport (GO:0070633) | 3.19850076 |
| 130 | regulation of systemic arterial blood pressure (GO:0003073) | 3.19531399 |
| 131 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.17448055 |
| 132 | vitamin D metabolic process (GO:0042359) | 3.16565717 |
| 133 | cGMP biosynthetic process (GO:0006182) | 3.15814172 |
| 134 | L-ascorbic acid metabolic process (GO:0019852) | 3.14283715 |
| 135 | negative regulation of digestive system process (GO:0060457) | 3.12062571 |
| 136 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.11399844 |
| 137 | regulation of penile erection (GO:0060405) | 3.08517341 |
| 138 | phenylpropanoid metabolic process (GO:0009698) | 3.08133609 |
| 139 | cellular carbohydrate catabolic process (GO:0044275) | 3.07678421 |
| 140 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.05723831 |
| 141 | polyol transport (GO:0015791) | 3.05681293 |
| 142 | transcytosis (GO:0045056) | 3.02736034 |
| 143 | bicarbonate transport (GO:0015701) | 3.01908894 |
| 144 | mature B cell differentiation involved in immune response (GO:0002313) | 2.99812591 |
| 145 | glycerol metabolic process (GO:0006071) | 2.99776825 |
| 146 | sperm capacitation (GO:0048240) | 2.96469222 |
| 147 | lipid homeostasis (GO:0055088) | 2.93597618 |
| 148 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.91689432 |
| 149 | histamine secretion (GO:0001821) | 2.91111058 |
| 150 | intestinal absorption (GO:0050892) | 13.0285239 |
| 151 | angiotensin maturation (GO:0002003) | 12.2390393 |
| 152 | intestinal cholesterol absorption (GO:0030299) | 12.0196978 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 9.08732342 |
| 2 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 5.21845315 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.48076395 |
| 4 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.39103099 |
| 5 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 3.23604908 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.10474418 |
| 7 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.97969664 |
| 8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.92396420 |
| 9 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.76722007 |
| 10 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.68548777 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.65041903 |
| 12 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.52551971 |
| 13 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.51002154 |
| 14 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.49913709 |
| 15 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.45569004 |
| 16 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.26134813 |
| 17 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.99849882 |
| 18 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.90909368 |
| 19 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.90360377 |
| 20 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.87672458 |
| 21 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.75223153 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.74290160 |
| 23 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.69942672 |
| 24 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.69346999 |
| 25 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.66861974 |
| 26 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.58354805 |
| 27 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.56295205 |
| 28 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.52454676 |
| 29 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.50415850 |
| 30 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.49735803 |
| 31 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.49259099 |
| 32 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.48408072 |
| 33 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.47426497 |
| 34 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.46622940 |
| 35 | GATA1_22025678_ChIP-Seq_K562_Human | 1.45667000 |
| 36 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.45264346 |
| 37 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.44539481 |
| 38 | GATA2_19941826_ChIP-Seq_K562_Human | 1.43764788 |
| 39 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.43210581 |
| 40 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.41526236 |
| 41 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.41466537 |
| 42 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.39193998 |
| 43 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.39042910 |
| 44 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.36655944 |
| 45 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.34365549 |
| 46 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.32470528 |
| 47 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.31690663 |
| 48 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.31557761 |
| 49 | ATF3_27146783_Chip-Seq_COLON_Human | 1.30299442 |
| 50 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.28907466 |
| 51 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20977837 |
| 52 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.19967045 |
| 53 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.19252218 |
| 54 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.18875229 |
| 55 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.15997704 |
| 56 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.14073443 |
| 57 | SA1_27219007_Chip-Seq_Bcells_Human | 1.13255918 |
| 58 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.13015824 |
| 59 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.12344228 |
| 60 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.12153703 |
| 61 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.10874282 |
| 62 | RXR_22108803_ChIP-Seq_LS180_Human | 1.10263873 |
| 63 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.08026042 |
| 64 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.07391287 |
| 65 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.07325381 |
| 66 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.04930474 |
| 67 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.04425691 |
| 68 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.03980176 |
| 69 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.03381576 |
| 70 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.03056535 |
| 71 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.02838414 |
| 72 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02515139 |
| 73 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02039206 |
| 74 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01730948 |
| 75 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.01256039 |
| 76 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.01089283 |
| 77 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.00861139 |
| 78 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.98032348 |
| 79 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.97415709 |
| 80 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.96858602 |
| 81 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.96128889 |
| 82 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.95898235 |
| 83 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.95525907 |
| 84 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.94491711 |
| 85 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.94231416 |
| 86 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.94230016 |
| 87 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94021656 |
| 88 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.93443733 |
| 89 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.92853891 |
| 90 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.92733123 |
| 91 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.91184530 |
| 92 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.91160936 |
| 93 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.90098576 |
| 94 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.88926842 |
| 95 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.88454695 |
| 96 | GATA1_19941826_ChIP-Seq_K562_Human | 0.88425581 |
| 97 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.88269049 |
| 98 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.88168451 |
| 99 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.87965868 |
| 100 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.86493728 |
| 101 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.85669692 |
| 102 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.84386724 |
| 103 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.84225113 |
| 104 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.84176990 |
| 105 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.83332447 |
| 106 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.83249051 |
| 107 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.82179068 |
| 108 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.81812484 |
| 109 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.81694449 |
| 110 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.81217600 |
| 111 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81092564 |
| 112 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.80524828 |
| 113 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.79343638 |
| 114 | VDR_22108803_ChIP-Seq_LS180_Human | 0.78917381 |
| 115 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.78608570 |
| 116 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.78269677 |
| 117 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.77803615 |
| 118 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.77691326 |
| 119 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.77077181 |
| 120 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.77035614 |
| 121 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.76999648 |
| 122 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.76281185 |
| 123 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.76178210 |
| 124 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.76076773 |
| 125 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.75564831 |
| 126 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.75520761 |
| 127 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.75218064 |
| 128 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.75165230 |
| 129 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.74719166 |
| 130 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.73796972 |
| 131 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.72638044 |
| 132 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.72638044 |
| 133 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.71006286 |
| 134 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.70373765 |
| 135 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.68995292 |
| 136 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.68942403 |
| 137 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.67889147 |
| 138 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.67533397 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009840_abnormal_foam_cell | 5.66094535 |
| 2 | * MP0001666_abnormal_nutrient_absorption | 5.26600580 |
| 3 | MP0003183_abnormal_peptide_metabolism | 4.66346315 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 3.99415050 |
| 5 | MP0010234_abnormal_vibrissa_follicle | 3.75725007 |
| 6 | MP0003252_abnormal_bile_duct | 3.34372681 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.22876739 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.12399468 |
| 9 | MP0004264_abnormal_extraembryonic_tissu | 3.03661617 |
| 10 | MP0000462_abnormal_digestive_system | 3.03291061 |
| 11 | MP0005085_abnormal_gallbladder_physiolo | 2.85081109 |
| 12 | MP0003866_abnormal_defecation | 2.50638323 |
| 13 | MP0004147_increased_porphyrin_level | 2.26645474 |
| 14 | MP0002822_catalepsy | 2.13165188 |
| 15 | MP0005409_darkened_coat_color | 2.09525708 |
| 16 | MP0005360_urolithiasis | 10.2517054 |
| 17 | MP0005084_abnormal_gallbladder_morpholo | 1.99081015 |
| 18 | MP0009697_abnormal_copulation | 1.91810443 |
| 19 | MP0000537_abnormal_urethra_morphology | 1.85867879 |
| 20 | MP0004043_abnormal_pH_regulation | 1.74801604 |
| 21 | MP0003878_abnormal_ear_physiology | 1.71296106 |
| 22 | MP0005377_hearing/vestibular/ear_phenot | 1.71296106 |
| 23 | MP0003868_abnormal_feces_composition | 1.67661639 |
| 24 | MP0001664_abnormal_digestion | 1.66785185 |
| 25 | MP0002254_reproductive_system_inflammat | 1.61670134 |
| 26 | MP0005381_digestive/alimentary_phenotyp | 1.61636156 |
| 27 | MP0005448_abnormal_energy_balance | 1.60146250 |
| 28 | MP0003705_abnormal_hypodermis_morpholog | 1.57584325 |
| 29 | MP0001663_abnormal_digestive_system | 1.57542489 |
| 30 | MP0005670_abnormal_white_adipose | 1.57373682 |
| 31 | MP0003191_abnormal_cellular_cholesterol | 1.54533948 |
| 32 | MP0000538_abnormal_urinary_bladder | 1.53221664 |
| 33 | MP0005365_abnormal_bile_salt | 1.50637681 |
| 34 | MP0002089_abnormal_postnatal_growth/wei | 1.47447094 |
| 35 | MP0010352_gastrointestinal_tract_polyps | 1.46861700 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.43627775 |
| 37 | MP0002796_impaired_skin_barrier | 1.43339858 |
| 38 | MP0003300_gastrointestinal_ulcer | 1.41585619 |
| 39 | MP0004858_abnormal_nervous_system | 1.37964170 |
| 40 | MP0006054_spinal_hemorrhage | 1.35335571 |
| 41 | MP0000477_abnormal_intestine_morphology | 1.33593527 |
| 42 | MP0001188_hyperpigmentation | 1.32381912 |
| 43 | MP0001873_stomach_inflammation | 1.32319460 |
| 44 | MP0009379_abnormal_foot_pigmentation | 1.30404190 |
| 45 | MP0005332_abnormal_amino_acid | 1.19293626 |
| 46 | MP0002118_abnormal_lipid_homeostasis | 1.14959756 |
| 47 | MP0001501_abnormal_sleep_pattern | 1.14487691 |
| 48 | MP0000490_abnormal_crypts_of | 1.12364627 |
| 49 | MP0004270_analgesia | 1.09661327 |
| 50 | MP0004782_abnormal_surfactant_physiolog | 1.07751722 |
| 51 | MP0000609_abnormal_liver_physiology | 1.04055214 |
| 52 | MP0005535_abnormal_body_temperature | 1.02150786 |
| 53 | MP0003806_abnormal_nucleotide_metabolis | 1.01059269 |
| 54 | MP0009643_abnormal_urine_homeostasis | 0.98713367 |
| 55 | MP0000467_abnormal_esophagus_morphology | 0.94776883 |
| 56 | MP0001849_ear_inflammation | 0.93446319 |
| 57 | * MP0004019_abnormal_vitamin_homeostasis | 0.93412555 |
| 58 | MP0009780_abnormal_chondrocyte_physiolo | 0.93046095 |
| 59 | MP0004947_skin_inflammation | 0.89569060 |
| 60 | MP0001845_abnormal_inflammatory_respons | 0.86816879 |
| 61 | MP0001756_abnormal_urination | 0.86437239 |
| 62 | MP0005501_abnormal_skin_physiology | 0.85358287 |
| 63 | MP0005167_abnormal_blood-brain_barrier | 0.83538361 |
| 64 | MP0008872_abnormal_physiological_respon | 0.82666480 |
| 65 | MP0003283_abnormal_digestive_organ | 0.78672728 |
| 66 | MP0005266_abnormal_metabolism | 0.78446444 |
| 67 | MP0010678_abnormal_skin_adnexa | 0.78412833 |
| 68 | MP0009053_abnormal_anal_canal | 0.76764213 |
| 69 | MP0002396_abnormal_hematopoietic_system | 0.76437790 |
| 70 | MP0005451_abnormal_body_composition | 0.76235085 |
| 71 | MP0002876_abnormal_thyroid_physiology | 0.75140730 |
| 72 | MP0002098_abnormal_vibrissa_morphology | 0.74088772 |
| 73 | MP0000516_abnormal_urinary_system | 0.73641013 |
| 74 | MP0005367_renal/urinary_system_phenotyp | 0.73641013 |
| 75 | MP0008469_abnormal_protein_level | 0.73540980 |
| 76 | MP0009785_altered_susceptibility_to | 0.68745440 |
| 77 | MP0001485_abnormal_pinna_reflex | 0.68452959 |
| 78 | MP0001764_abnormal_homeostasis | 0.67351281 |
| 79 | MP0005319_abnormal_enzyme/_coenzyme | 0.67083920 |
| 80 | MP0005166_decreased_susceptibility_to | 0.67012417 |
| 81 | MP0002166_altered_tumor_susceptibility | 0.66873324 |
| 82 | MP0003724_increased_susceptibility_to | 0.64606542 |
| 83 | MP0000465_gastrointestinal_hemorrhage | 0.63966753 |
| 84 | MP0003879_abnormal_hair_cell | 0.63794752 |
| 85 | MP0005666_abnormal_adipose_tissue | 0.62616572 |
| 86 | MP0003638_abnormal_response/metabolism_ | 0.61259677 |
| 87 | MP0000604_amyloidosis | 0.60820010 |
| 88 | MP0006138_congestive_heart_failure | 0.60222802 |
| 89 | MP0003329_amyloid_beta_deposits | 0.59036208 |
| 90 | MP0003950_abnormal_plasma_membrane | 0.58880283 |
| 91 | MP0006082_CNS_inflammation | 0.58680150 |
| 92 | MP0003453_abnormal_keratinocyte_physiol | 0.58193349 |
| 93 | MP0009765_abnormal_xenobiotic_induced | 0.58012638 |
| 94 | MP0009384_cardiac_valve_regurgitation | 0.56869182 |
| 95 | MP0009642_abnormal_blood_homeostasis | 0.56731811 |
| 96 | MP0005174_abnormal_tail_pigmentation | 0.56466012 |
| 97 | MP0001765_abnormal_ion_homeostasis | 0.56389607 |
| 98 | MP0009115_abnormal_fat_cell | 0.56316530 |
| 99 | MP0001835_abnormal_antigen_presentation | 0.55926900 |
| 100 | MP0005025_abnormal_response_to | 0.55268316 |
| 101 | MP0002136_abnormal_kidney_physiology | 0.55209035 |
| 102 | MP0005636_abnormal_mineral_homeostasis | 0.54136614 |
| 103 | MP0005376_homeostasis/metabolism_phenot | 0.53062660 |
| 104 | MP0001216_abnormal_epidermal_layer | 0.52289682 |
| 105 | MP0000678_abnormal_parathyroid_gland | 0.51561661 |
| 106 | MP0003953_abnormal_hormone_level | 0.51554665 |
| 107 | MP0005387_immune_system_phenotype | 0.50344559 |
| 108 | MP0001790_abnormal_immune_system | 0.50344559 |
| 109 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.48248970 |
| 110 | MP0003436_decreased_susceptibility_to | 0.46855415 |
| 111 | MP0002896_abnormal_bone_mineralization | 0.46280164 |
| 112 | MP0003315_abnormal_perineum_morphology | 0.45272946 |
| 113 | MP0001191_abnormal_skin_condition | 0.44679537 |
| 114 | MP0009333_abnormal_splenocyte_physiolog | 0.44426622 |
| 115 | MP0005058_abnormal_lysosome_morphology | 0.44221859 |
| 116 | MP0000579_abnormal_nail_morphology | 0.43966585 |
| 117 | MP0002138_abnormal_hepatobiliary_system | 0.43940625 |
| 118 | MP0005165_increased_susceptibility_to | 0.43635240 |
| 119 | MP0000427_abnormal_hair_cycle | 0.43211615 |
| 120 | MP0003656_abnormal_erythrocyte_physiolo | 0.42202134 |
| 121 | MP0000230_abnormal_systemic_arterial | 0.42114306 |
| 122 | MP0002971_abnormal_brown_adipose | 0.41474150 |
| 123 | MP0002078_abnormal_glucose_homeostasis | 0.38938501 |
| 124 | MP0009764_decreased_sensitivity_to | 0.38870769 |
| 125 | MP0000249_abnormal_blood_vessel | 0.37825957 |
| 126 | MP0001881_abnormal_mammary_gland | 0.37760628 |
| 127 | MP0005334_abnormal_fat_pad | 0.36837843 |
| 128 | MP0000598_abnormal_liver_morphology | 0.34766580 |
| 129 | MP0000470_abnormal_stomach_morphology | 0.34637900 |
| 130 | MP0008873_increased_physiological_sensi | 0.33989217 |
| 131 | MP0000377_abnormal_hair_follicle | 0.32310393 |
| 132 | MP0005023_abnormal_wound_healing | 0.31980991 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ileus (HP:0002595) | 8.38233609 |
| 2 | Acanthocytosis (HP:0001927) | 7.94960425 |
| 3 | Hypobetalipoproteinemia (HP:0003563) | 7.93831400 |
| 4 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 7.43353035 |
| 5 | Autoimmune thrombocytopenia (HP:0001973) | 6.84728409 |
| 6 | Abnormality of proline metabolism (HP:0010907) | 5.78696351 |
| 7 | Hydroxyprolinuria (HP:0003080) | 5.78696351 |
| 8 | Malnutrition (HP:0004395) | 5.76909192 |
| 9 | Cupped ribs (HP:0000887) | 5.06052967 |
| 10 | Conjugated hyperbilirubinemia (HP:0002908) | 5.05435411 |
| 11 | Autoimmune hemolytic anemia (HP:0001890) | 4.99685963 |
| 12 | Pigmentary retinal degeneration (HP:0001146) | 4.99162530 |
| 13 | Hypolipoproteinemia (HP:0010981) | 4.68578834 |
| 14 | Right ventricular cardiomyopathy (HP:0011663) | 4.68391050 |
| 15 | Poikilocytosis (HP:0004447) | 4.52925034 |
| 16 | Increased IgE level (HP:0003212) | 4.39045791 |
| 17 | Widely patent fontanelles and sutures (HP:0004492) | 4.27288460 |
| 18 | Mesangial abnormality (HP:0001966) | 4.21733840 |
| 19 | Systemic lupus erythematosus (HP:0002725) | 4.13258628 |
| 20 | Facial shape deformation (HP:0011334) | 4.07702420 |
| 21 | Potter facies (HP:0002009) | 4.07702420 |
| 22 | Fat malabsorption (HP:0002630) | 4.07478832 |
| 23 | Proximal tubulopathy (HP:0000114) | 3.82093198 |
| 24 | Hyperglycinuria (HP:0003108) | 3.64226253 |
| 25 | Abnormality of B cell number (HP:0010975) | 3.63670652 |
| 26 | B lymphocytopenia (HP:0010976) | 3.63670652 |
| 27 | Chronic diarrhea (HP:0002028) | 3.63522169 |
| 28 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.63105916 |
| 29 | Xanthomatosis (HP:0000991) | 3.49653806 |
| 30 | Abdominal distention (HP:0003270) | 3.44350266 |
| 31 | Glycosuria (HP:0003076) | 3.42448617 |
| 32 | Abnormality of urine glucose concentration (HP:0011016) | 3.42448617 |
| 33 | Severe combined immunodeficiency (HP:0004430) | 3.33315520 |
| 34 | Abnormal glucose tolerance (HP:0001952) | 3.19808574 |
| 35 | Increased purine levels (HP:0004368) | 3.18514066 |
| 36 | Hyperuricemia (HP:0002149) | 3.18514066 |
| 37 | Steatorrhea (HP:0002570) | 3.07173147 |
| 38 | Gastrointestinal dysmotility (HP:0002579) | 3.02541935 |
| 39 | Combined immunodeficiency (HP:0005387) | 2.99838500 |
| 40 | Posterior subcapsular cataract (HP:0007787) | 2.98667660 |
| 41 | Reticulocytosis (HP:0001923) | 2.95936044 |
| 42 | Decreased circulating renin level (HP:0003351) | 2.94806733 |
| 43 | Thyroiditis (HP:0100646) | 2.94369324 |
| 44 | Dehydration (HP:0001944) | 2.93457462 |
| 45 | Alkalosis (HP:0001948) | 2.90561801 |
| 46 | Wide cranial sutures (HP:0010537) | 2.82992929 |
| 47 | Hypercholesterolemia (HP:0003124) | 2.78446106 |
| 48 | Nephrolithiasis (HP:0000787) | 2.77424723 |
| 49 | Hyperactive renin-angiotensin system (HP:0000841) | 2.77028728 |
| 50 | Increased mean platelet volume (HP:0011877) | 2.69966566 |
| 51 | Metabolic alkalosis (HP:0200114) | 2.67010565 |
| 52 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.65085424 |
| 53 | Eczematoid dermatitis (HP:0000976) | 2.62191656 |
| 54 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.59040413 |
| 55 | Polycythemia (HP:0001901) | 2.55839889 |
| 56 | Enlarged epiphyses (HP:0010580) | 2.52879102 |
| 57 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.52411236 |
| 58 | Abnormality of glycine metabolism (HP:0010895) | 2.48652035 |
| 59 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.48652035 |
| 60 | Abnormality of purine metabolism (HP:0004352) | 2.47772474 |
| 61 | Epidermoid cyst (HP:0200040) | 2.45845187 |
| 62 | Abnormality of vitamin B metabolism (HP:0004340) | 2.41091473 |
| 63 | Delayed epiphyseal ossification (HP:0002663) | 2.39013179 |
| 64 | Focal segmental glomerulosclerosis (HP:0000097) | 2.36860207 |
| 65 | Metabolic acidosis (HP:0001942) | 2.36549247 |
| 66 | Abnormal platelet volume (HP:0011876) | 2.35989042 |
| 67 | Hyperphosphaturia (HP:0003109) | 2.35694044 |
| 68 | Abnormal gallbladder physiology (HP:0012438) | 2.34367671 |
| 69 | Cholecystitis (HP:0001082) | 2.34367671 |
| 70 | Hypotension (HP:0002615) | 2.32365039 |
| 71 | Gout (HP:0001997) | 2.32272092 |
| 72 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.29465870 |
| 73 | Intrahepatic cholestasis (HP:0001406) | 2.28635932 |
| 74 | Abnormality of renin-angiotensin system (HP:0000847) | 2.25421881 |
| 75 | Abnormality of the costochondral junction (HP:0000919) | 2.25098825 |
| 76 | Palpitations (HP:0001962) | 2.22151422 |
| 77 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.21656668 |
| 78 | Abnormality of the gastric mucosa (HP:0004295) | 2.19824379 |
| 79 | Subcapsular cataract (HP:0000523) | 2.19731085 |
| 80 | Abnormality of magnesium homeostasis (HP:0004921) | 2.17791112 |
| 81 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.16511663 |
| 82 | Abnormality of eosinophils (HP:0001879) | 2.13015765 |
| 83 | Villous atrophy (HP:0011473) | 2.11137632 |
| 84 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.11137632 |
| 85 | Abnormality of vitamin metabolism (HP:0100508) | 2.09118720 |
| 86 | Cerebral palsy (HP:0100021) | 2.08996894 |
| 87 | Hemorrhage of the eye (HP:0011885) | 2.08990703 |
| 88 | Woolly hair (HP:0002224) | 2.08445841 |
| 89 | Progressive sensorineural hearing impairment (HP:0000408) | 2.07554586 |
| 90 | Protuberant abdomen (HP:0001538) | 2.07252831 |
| 91 | Dicarboxylic aciduria (HP:0003215) | 2.06927507 |
| 92 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.06927507 |
| 93 | Nausea (HP:0002018) | 2.06451903 |
| 94 | Renal tubular acidosis (HP:0001947) | 2.04679979 |
| 95 | Pili torti (HP:0003777) | 2.04259028 |
| 96 | Rectal prolapse (HP:0002035) | 2.03996184 |
| 97 | Eosinophilia (HP:0001880) | 2.02715561 |
| 98 | Irritability (HP:0000737) | 2.01560641 |
| 99 | Abnormal biliary tract morphology (HP:0012440) | 2.01107111 |
| 100 | Hyperphosphatemia (HP:0002905) | 2.00781516 |
| 101 | Myopathic facies (HP:0002058) | 2.00523557 |
| 102 | Glomerulonephritis (HP:0000099) | 1.99085071 |
| 103 | Abnormality of nucleobase metabolism (HP:0010932) | 1.98888960 |
| 104 | Abnormal urine phosphate concentration (HP:0012599) | 1.98281754 |
| 105 | Confusion (HP:0001289) | 1.94811729 |
| 106 | Flat acetabular roof (HP:0003180) | 1.94552430 |
| 107 | Goiter (HP:0000853) | 1.93990108 |
| 108 | Hyperbilirubinemia (HP:0002904) | 1.93681943 |
| 109 | Congenital sensorineural hearing impairment (HP:0008527) | 1.91556949 |
| 110 | Syncope (HP:0001279) | 1.91064405 |
| 111 | Gingivitis (HP:0000230) | 1.90040122 |
| 112 | Milia (HP:0001056) | 1.89043076 |
| 113 | Hyperparathyroidism (HP:0000843) | 1.88534012 |
| 114 | Amyloidosis (HP:0011034) | 1.87410373 |
| 115 | Hypoalbuminemia (HP:0003073) | 1.85810062 |
| 116 | Abnormal albumin level (HP:0012116) | 1.85810062 |
| 117 | Hyperammonemia (HP:0001987) | 1.85677339 |
| 118 | Growth hormone excess (HP:0000845) | 1.85622424 |
| 119 | Renal tubular dysfunction (HP:0000124) | 1.85161567 |
| 120 | Megaloblastic anemia (HP:0001889) | 1.84331329 |
| 121 | Abnormality of complement system (HP:0005339) | 1.83461274 |
| 122 | Pustule (HP:0200039) | 1.81225789 |
| 123 | Abnormality of the 1st metacarpal (HP:0010009) | 1.80155135 |
| 124 | Complement deficiency (HP:0004431) | 1.79951074 |
| 125 | Cheilitis (HP:0100825) | 1.77326644 |
| 126 | Nephritis (HP:0000123) | 1.77210217 |
| 127 | Glomerulosclerosis (HP:0000096) | 1.77001082 |
| 128 | Multiple lipomas (HP:0001012) | 1.76844037 |
| 129 | Progressive hearing impairment (HP:0001730) | 1.74995493 |
| 130 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.73677178 |
| 131 | Granulocytopenia (HP:0001913) | 1.73530980 |
| 132 | Thin bony cortex (HP:0002753) | 1.73452945 |
| 133 | White forelock (HP:0002211) | 1.73429686 |
| 134 | Pancreatitis (HP:0001733) | 1.72933916 |
| 135 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.72874638 |
| 136 | Abnormal platelet function (HP:0011869) | 1.72696629 |
| 137 | Impaired platelet aggregation (HP:0003540) | 1.72696629 |
| 138 | Nonimmune hydrops fetalis (HP:0001790) | 1.72415955 |
| 139 | Lethargy (HP:0001254) | 1.71411922 |
| 140 | Symptomatic seizures (HP:0011145) | 1.70630226 |
| 141 | Patchy hypopigmentation of hair (HP:0011365) | 1.70512496 |
| 142 | Alopecia of scalp (HP:0002293) | 1.69478395 |
| 143 | Peripheral demyelination (HP:0011096) | 1.68741611 |
| 144 | Hypophosphatemia (HP:0002148) | 1.64571594 |
| 145 | Hypocalcemia (HP:0002901) | 1.63875432 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 8.91168238 |
| 2 | FRK | 6.13938828 |
| 3 | MST4 | 5.58052434 |
| 4 | LMTK2 | 4.82212554 |
| 5 | MST1R | 4.57815196 |
| 6 | GRK6 | 3.81040752 |
| 7 | PRKG2 | 3.47879693 |
| 8 | NME1 | 3.27838243 |
| 9 | EPHA2 | 2.93730705 |
| 10 | AKT3 | 2.81260441 |
| 11 | RIPK1 | 2.61140633 |
| 12 | MAP3K10 | 2.56814340 |
| 13 | MAP3K2 | 2.32277679 |
| 14 | STK39 | 2.28190280 |
| 15 | NUAK1 | 2.19479791 |
| 16 | PTK6 | 2.18579192 |
| 17 | ERN1 | 2.13216752 |
| 18 | MAP2K2 | 2.10687833 |
| 19 | OXSR1 | 1.90894164 |
| 20 | EPHA3 | 1.72524661 |
| 21 | MET | 1.70869550 |
| 22 | EPHB2 | 1.70368165 |
| 23 | TESK2 | 1.63570975 |
| 24 | TESK1 | 1.51111529 |
| 25 | PIK3CG | 1.43264714 |
| 26 | STK10 | 1.34643610 |
| 27 | TAOK1 | 1.29114847 |
| 28 | STK24 | 1.23714981 |
| 29 | EPHA4 | 1.22265153 |
| 30 | BMX | 1.17199068 |
| 31 | KSR2 | 1.13840302 |
| 32 | DDR2 | 1.08539538 |
| 33 | EPHB1 | 1.08365387 |
| 34 | FGFR3 | 1.04053836 |
| 35 | MAP3K11 | 1.00902798 |
| 36 | NLK | 1.00174594 |
| 37 | FER | 1.00171106 |
| 38 | PRKCI | 0.97738610 |
| 39 | MAP3K8 | 0.95841839 |
| 40 | PTK2 | 0.95478592 |
| 41 | MAP2K6 | 0.92391541 |
| 42 | MATK | 0.91927554 |
| 43 | RIPK4 | 0.91809969 |
| 44 | PRPF4B | 0.82311715 |
| 45 | PIM1 | 0.81823366 |
| 46 | MAP3K7 | 0.81721187 |
| 47 | PAK4 | 0.80331342 |
| 48 | MUSK | 0.79040310 |
| 49 | PRKAA2 | 0.77658711 |
| 50 | MYLK | 0.77066006 |
| 51 | LATS1 | 0.73827397 |
| 52 | BMPR2 | 0.72548476 |
| 53 | CASK | 0.72285985 |
| 54 | CDC42BPA | 0.72202713 |
| 55 | MAP3K9 | 0.71856249 |
| 56 | MAP3K1 | 0.70821155 |
| 57 | TBK1 | 0.70524340 |
| 58 | TTK | 0.69559032 |
| 59 | MAP2K1 | 0.69551474 |
| 60 | ERBB2 | 0.69285384 |
| 61 | PBK | 0.67859331 |
| 62 | SCYL2 | 0.66324228 |
| 63 | PRKCZ | 0.65953979 |
| 64 | CDK19 | 0.65945690 |
| 65 | MAP3K3 | 0.65863536 |
| 66 | IRAK1 | 0.61764440 |
| 67 | TAOK3 | 0.61648154 |
| 68 | MAPK11 | 0.59317270 |
| 69 | JAK1 | 0.54224426 |
| 70 | ICK | 0.52170630 |
| 71 | PDPK1 | 0.52006576 |
| 72 | LIMK1 | 0.51769389 |
| 73 | LRRK2 | 0.51400126 |
| 74 | PIM2 | 0.50951766 |
| 75 | ERBB4 | 0.50312327 |
| 76 | ABL2 | 0.46042184 |
| 77 | YES1 | 0.45281782 |
| 78 | PAK3 | 0.43186470 |
| 79 | MAP3K12 | 0.41947052 |
| 80 | TYK2 | 0.41422099 |
| 81 | JAK2 | 0.40237545 |
| 82 | PRKAA1 | 0.36954967 |
| 83 | DYRK1B | 0.35426036 |
| 84 | CSF1R | 0.35254178 |
| 85 | IKBKE | 0.34780824 |
| 86 | MAP4K1 | 0.34139711 |
| 87 | CSK | 0.33780871 |
| 88 | PIK3CA | 0.33216055 |
| 89 | DMPK | 0.32540117 |
| 90 | NEK6 | 0.32532634 |
| 91 | MAPKAPK2 | 0.32392685 |
| 92 | BTK | 0.32083634 |
| 93 | PDK1 | 0.31947504 |
| 94 | PDK2 | 0.31859443 |
| 95 | SRC | 0.30908353 |
| 96 | SYK | 0.30058456 |
| 97 | TEC | 0.29774446 |
| 98 | PRKCA | 0.29771844 |
| 99 | CAMK2B | 0.27614166 |
| 100 | PKN2 | 0.27241381 |
| 101 | CDK6 | 0.26752084 |
| 102 | CSNK1A1 | 0.26154615 |
| 103 | PRKACG | 0.25183714 |
| 104 | PAK1 | 0.24447719 |
| 105 | FYN | 0.24178950 |
| 106 | ZAP70 | 0.24165678 |
| 107 | FGR | 0.24086156 |
| 108 | TNIK | 0.23914305 |
| 109 | PDGFRA | 0.23024117 |
| 110 | PAK2 | 0.22417052 |
| 111 | PRKCQ | 0.22259360 |
| 112 | PRKCD | 0.22141819 |
| 113 | TYRO3 | 0.20737415 |
| 114 | AKT2 | 0.20513628 |
| 115 | PRKACA | 0.20292941 |
| 116 | ROCK1 | 0.19834266 |
| 117 | STK3 | 0.19178868 |
| 118 | GRK1 | 0.18829530 |
| 119 | DAPK2 | 0.18333890 |
| 120 | LYN | 0.18230390 |
| 121 | IRAK4 | 0.18116643 |
| 122 | IGF1R | 0.16602610 |
| 123 | LCK | 0.16431407 |
| 124 | ARAF | 0.15447806 |
| 125 | CAMK2D | 0.13807343 |
| 126 | MELK | 0.13785508 |
| 127 | GSK3A | 0.13460619 |
| 128 | FGFR4 | 0.13075471 |
| 129 | CDK5 | 0.12890471 |
| 130 | CAMK2G | 0.12674153 |
| 131 | IRAK3 | 0.11759624 |
| 132 | BRAF | 0.10997966 |
| 133 | ITK | 0.10490721 |
| 134 | RET | 0.09573985 |
| 135 | STK11 | 0.08639174 |
| 136 | MAPK4 | 0.07461681 |
| 137 | PRKCB | 0.06737181 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fat digestion and absorption_Homo sapiens_hsa04975 | 6.78854034 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 4.93584894 |
| 3 | Renin-angiotensin system_Homo sapiens_hsa04614 | 4.91456237 |
| 4 | Mineral absorption_Homo sapiens_hsa04978 | 4.10141049 |
| 5 | * Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.18940906 |
| 6 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.06312506 |
| 7 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 2.98216230 |
| 8 | Galactose metabolism_Homo sapiens_hsa00052 | 2.93703560 |
| 9 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.72541244 |
| 10 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.41565366 |
| 11 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.37334834 |
| 12 | Bile secretion_Homo sapiens_hsa04976 | 1.95100667 |
| 13 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.92798447 |
| 14 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.92677602 |
| 15 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.81518610 |
| 16 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.80211252 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 1.64838488 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.50477567 |
| 19 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.49552136 |
| 20 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.38504117 |
| 21 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.37043677 |
| 22 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.34628684 |
| 23 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.31373606 |
| 24 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.23627016 |
| 25 | Asthma_Homo sapiens_hsa05310 | 1.17304571 |
| 26 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.15575537 |
| 27 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.13209335 |
| 28 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.12895281 |
| 29 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.09726393 |
| 30 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.09148817 |
| 31 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.08678390 |
| 32 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.06818129 |
| 33 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.02194398 |
| 34 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.01479233 |
| 35 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.01459661 |
| 36 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.92622152 |
| 37 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.92403383 |
| 38 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.90823958 |
| 39 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.86151897 |
| 40 | ABC transporters_Homo sapiens_hsa02010 | 0.80906728 |
| 41 | Allograft rejection_Homo sapiens_hsa05330 | 0.77036708 |
| 42 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.71403169 |
| 43 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.69890306 |
| 44 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.69688601 |
| 45 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.69083421 |
| 46 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.67912231 |
| 47 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.66203319 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 0.66155619 |
| 49 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.64178963 |
| 50 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.64157801 |
| 51 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.62809458 |
| 52 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60094823 |
| 53 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.56533621 |
| 54 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.51660363 |
| 55 | Retinol metabolism_Homo sapiens_hsa00830 | 0.51592933 |
| 56 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.51414033 |
| 57 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.51022893 |
| 58 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.50789181 |
| 59 | Tight junction_Homo sapiens_hsa04530 | 0.49252123 |
| 60 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.44803483 |
| 61 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.44649095 |
| 62 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.42218169 |
| 63 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.41399342 |
| 64 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.38013469 |
| 65 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.37335597 |
| 66 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.36785409 |
| 67 | Other glycan degradation_Homo sapiens_hsa00511 | 0.34950419 |
| 68 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.34277811 |
| 69 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.34236016 |
| 70 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.33425906 |
| 71 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.32600962 |
| 72 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.31736574 |
| 73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31277008 |
| 74 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.31146965 |
| 75 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.30681755 |
| 76 | Peroxisome_Homo sapiens_hsa04146 | 0.27222466 |
| 77 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.26931829 |
| 78 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.25225079 |
| 79 | Thyroid cancer_Homo sapiens_hsa05216 | 0.23785449 |
| 80 | Leishmaniasis_Homo sapiens_hsa05140 | 0.22767111 |
| 81 | Salmonella infection_Homo sapiens_hsa05132 | 0.22681815 |
| 82 | Metabolic pathways_Homo sapiens_hsa01100 | 0.22281481 |
| 83 | Bladder cancer_Homo sapiens_hsa05219 | 0.22237446 |
| 84 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.22180295 |
| 85 | Renin secretion_Homo sapiens_hsa04924 | 0.22074338 |
| 86 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.21929596 |
| 87 | Cocaine addiction_Homo sapiens_hsa05030 | 0.21710358 |
| 88 | Sulfur relay system_Homo sapiens_hsa04122 | 0.20640014 |
| 89 | Hepatitis C_Homo sapiens_hsa05160 | 0.19244897 |
| 90 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.19013123 |
| 91 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.18856311 |
| 92 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.18586961 |
| 93 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.17965707 |
| 94 | Insulin secretion_Homo sapiens_hsa04911 | 0.16632480 |
| 95 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.16530551 |
| 96 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.16108002 |
| 97 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.15301454 |
| 98 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.15072568 |
| 99 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.14299624 |
| 100 | Salivary secretion_Homo sapiens_hsa04970 | 0.13353563 |
| 101 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.12583053 |
| 102 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.12501701 |
| 103 | Adherens junction_Homo sapiens_hsa04520 | 0.11058462 |
| 104 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.10457648 |
| 105 | Lysine degradation_Homo sapiens_hsa00310 | 0.10435391 |
| 106 | Pertussis_Homo sapiens_hsa05133 | 0.10160222 |
| 107 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.10130217 |
| 108 | Viral myocarditis_Homo sapiens_hsa05416 | 0.09484892 |
| 109 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.09146368 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.07826924 |
| 111 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.07750046 |
| 112 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.06847353 |
| 113 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.06308231 |
| 114 | Long-term depression_Homo sapiens_hsa04730 | 0.05018275 |
| 115 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.04759694 |
| 116 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.04723589 |
| 117 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.04230139 |
| 118 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.03939586 |
| 119 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.03567678 |
| 120 | Gap junction_Homo sapiens_hsa04540 | 0.01780419 |
| 121 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.01579604 |
| 122 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.01026202 |
| 123 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.00206245 |
| 124 | Vibrio cholerae infection_Homo sapiens_hsa05110 | -0.0234572 |
| 125 | Choline metabolism in cancer_Homo sapiens_hsa05231 | -0.0201401 |
| 126 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | -0.0009882 |

